Pirifibrate is a synthetic fibrate drug and antilipemic agent primarily used to treat hyperlipidemia by effectively lowering serum triglyceride and cholesterol levels. By activating peroxisome proliferator-activated… Read more
Pirifibrate is a synthetic fibrate drug and antilipemic agent primarily used to treat hyperlipidemia by effectively lowering serum triglyceride and cholesterol levels. By activating peroxisome proliferator-activated receptors, this medication enhances lipid metabolism to manage cardiovascular risk factors. This category features high-quality reference standards for Pirifibrate API, alongside associated impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling, method validation, and ongoing quality control. By utilizing these characterized reference materials, researchers can ensure the accuracy and precision of their analytical testing protocols, supporting both clinical research and regulatory compliance in the development and manufacture of lipid-lowering therapies.